Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03233906
Other study ID # IRB-16-188
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 20, 2017
Est. completion date August 2018

Study information

Verified date May 2018
Source California State Polytechnic University, Pomona
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to examine the effect of chia seed consumption on body composition, blood pressure, blood glucose, satiety, mood, joint pain, and dietary displacement in overweight and obese females (18-45years). It is hypothesized that consuming chia seeds will bring about a positive change in body composition (lower % body fat), satiety, mood, joint pain, and blood pressure, lower blood glucose levels, increased fiber and improved nutrient intake, in overweight/ obese females.


Description:

Specific Objectives: 1. Determine if chia seed diet addition of 10% of Kcals (CHIA) positively changes body composition in young, healthy, overweight/obese people (Tanita scale). A) Determine if CHIA will decrease blood pressure (monitor). 2. Determine if CHIA will decrease blood glucose (draw) 3. Determine if CHIA increases satiety and improves diet (recordings). 4. Determine if CHIA will decrease joint pain (questionnaire). 5. Determine if CHIA will increase positive mood changes (questionnaires) and increase blood serotonin levels (draw).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date August 2018
Est. primary completion date May 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- are a female.

- are between the ages of 18 and 45.

- are not averse to consuming chia seeds on a regular basis (at least six weeks).

- have not taken any medication for any chronic disease (heart, diabetes, cancer) for twelve weeks.

- have not taken any steroid or hormone medication in the last eight weeks, excluding birth control pills...

- do not consume excess amounts of nuts and seeds. - do not consume alcohol on a regular basis.

- are not currently on a diet plan.

- are not pregnant or plan to become pregnant.

Exclusion Criteria:

- are a child, teenager, woman, or male younger than 18 or older than 45.

- eat large quantities of chia seeds on a regular basis.

- are taking any steroid or hormone medication (other than birth control pills). - are taking laxatives or fiber containing supplements on a regular basis.

- are pregnant or become pregnant.

- are currently on a diet plan.

- have a known allergy to seeds.

- consume excess amounts of seeds or nuts.

- consume alcohol on a regular basis.

- have a pacemaker or metal pins or plates in the body.

Study Design


Intervention

Dietary Supplement:
Chia Seeds- Salvia Hispanica
Chia seed added-10% of kcals and a no-chia control diet. 10% will be calculated using the following formula: Harris-Benedict equation multiplied by the activity factor of 1.2, 1.375, and 1.55 depending on each participant's activity level based on the information provided on the initial screening form.

Locations

Country Name City State
United States California State Polytechnic University, Pomona Pomona California

Sponsors (1)

Lead Sponsor Collaborator
California State Polytechnic University, Pomona

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fasting plasma glucose 12-hour fasting plasma glucose levels will be assessed using a glucometer baseline
Primary Waist Circumference waist circumference will be measured for each participant baseline
Primary Caloric intake 9, 3-day diet journals will be collected using a paper method baseline
Primary Serotonin Urine serotonin levels will be assessed baseline
Primary Body Weight Tanita scale Baseline
Primary Body Mass Index Tanita sclae Baseline
Primary Body Fat Percentage Tanita scale Baseline
Primary Fasting plasma glucose 2-hour fasting plasma glucose levels will be assessed using a glucometer week 4
Primary Fasting plasma glucose 2-hour fasting plasma glucose levels will be assessed using a glucometer week 8
Primary Waist Circumference waist circumference will be measured for each participant week 4
Primary Waist Circumference waist will be measured for each participant week 8
Primary Caloric intake 9, 3-day diet journals will be collected using a paper method week 4
Primary Caloric intake 9, 3-day diet journals will be collected using a paper method week 8
Primary Serotonin Urine serotonin levels will be assessed week 4
Primary Serotonin Urine serotonin levels will be assessed week 8
Primary Body Weight tanita scale week 4
Primary Body weight tanita scale week 8
Primary Body mass index tanita scale week 4
Primary body mass index tanita scale week 8
Primary Body fat percentage tanita scale week 4
Primary Body fat percentage tanita scale week 8
Primary Hip Circumference Hip Circumference will be measured for each participant Baseline
Primary Hip Circumference Hip Circumference will be measured for each participant week 4
Primary Hip Circumference Hip Circumference will be measured for each participant week 8
Secondary Blood Pressure Blood pressure will be taken using an automatic blood pressure machine baseline
Secondary Blood Pressure Blood pressure will be taken using an automatic blood pressure machine week 4
Secondary Blood Pressure Blood pressure will be taken using an automatic blood pressure machine week 8
Secondary Joint Pain Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis baseline
Secondary Joint Pain Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis week 4
Secondary Joint Pain Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis week 8
Secondary Mood Major Depression Inventory Baseline
Secondary Mood Major Depression Inventory week 4
Secondary Mood Major Depression Inventory week 8
Secondary Physical Activity INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT Baseline
Secondary Physical Activity INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT week 4
Secondary Physical Activity INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT week 8
Secondary Sleep Quality Measuring sleep quality using the Pittsburgh Sleep Quality Index Baseline
Secondary Sleep Quality Measuring sleep quality using the Pittsburgh Sleep Quality Index week 4
Secondary Sleep Quality Measuring sleep quality using the Pittsburgh Sleep Quality Index week 8
Secondary Fat mass using a tanita scale Baseline
Secondary Fat mass using a tanita scale week 4
Secondary Fat mass using a tanita scale week 8
Secondary Fat Free Mass using a tanita scale Baseline
Secondary Fat Free Mass using a tanita scale week 4
Secondary Fat Free Mass using a tanita scale week 8
Secondary Total body water using a tanita scale Baseline
Secondary Total body water using a tanita scale week 4
Secondary Total body water using a tanita scale week 8
Secondary Macro nutrient intake 3, 3-day diet journals will be collected using a paper method Baseline
Secondary Macro nutrient intake 3, 3-day diet journals will be collected using a paper method week 4
Secondary Macro nutrient intake 3, 3-day diet journals will be collected using a paper method week 8
Secondary Micronutrient intake 3, 3-day diet journals will be collected using a paper method Baseline
Secondary Micronutrient intake 3, 3-day diet journals will be collected using a paper method week 4
Secondary Micronutrient intake 3, 3-day diet journals will be collected using a paper method week 8
Secondary Dietary intake Satiety 3, 3-day diet journals will be collected using a paper method Baseline
Secondary Dietary intake Satiety 3, 3-day diet journals will be collected using a paper method week 4
Secondary Dietary intake Satiety 3, 3-day diet journals will be collected using a paper method week 8
Secondary Dietary intake displacement 3, 3-day diet journals will be collected using a paper method Baseline
Secondary Dietary intake displacement 3, 3-day diet journals will be collected using a paper method week 4
Secondary Dietary intake displacement 3, 3-day diet journals will be collected using a paper method week 8
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2